Morten Herholdt
Stock Analyst at HSBC
(1.50)
# 3,251
Out of 4,843 analysts
17
Total ratings
41.67%
Success rate
-5.69%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $248.97 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $168.63 | +33.43% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $129.79 | +163.50% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $110.08 | -37.32% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $155.21 | +9.53% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $46 → $20 | $4.97 | +310.46% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $301.91 | +78.86% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $43.25 | +20.23% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $140.33 | +85.28% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $288.18 | +11.04% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.54 | +653.25% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $248.97
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $168.63
Upside: +33.43%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $129.79
Upside: +163.50%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $110.08
Upside: -37.32%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $155.21
Upside: +9.53%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $46 → $20
Current: $4.97
Upside: +310.46%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $301.91
Upside: +78.86%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $43.25
Upside: +20.23%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $140.33
Upside: +85.28%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $288.18
Upside: +11.04%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.54
Upside: +653.25%